Neonatal hyperbilirubinemia develops in approximately 50% of all term infants and 80% of all preterm infants. Neonatal hyperbilirubinemia, known as jaundice, is caused by the buildup of the compound bilirubin in the blood stream causing the skin and eyes to become discolored with a yellow hue. Bilirubin is a byproduct of decomposition of normal red blood cells, specifically from heme breakdown. Typically byproducts produced by the breakdown of red blood cells would processed through the kidneys then excreted through urine. However some newborns have not yet developed adequate kidney function that to effectively convert bilirubin into its water soluble isomers. This leads to a build up of bilirubin in the bloodstream and causes a yellowing of the skin and whites of the eyes. If jaundice is left untreated, it could lead to kernicterus which develops when unbonded bilirubin leaves the bloodstream and collects in brain tissue. This build up in the brain can cause brain damage and deafness. Typically jaundice can be treated by placing the infant into sunlight, which breaks down the bilirubin into its water soluble isomers that are easier for the kidney to excrete. In more severe cases, phototherapy is needed to breakdown the bilirubin and avoid a blood transfusion. My device incorporates both aspects of phototherapy; a noninvasive, comfortable strap that wraps around the infant's torso and a strong blue (465 nm) LED light bed that offers intense phototherapy. The light wrap provides efficacious irradiation levels and is functional at 10.5 volts. The device allows the infant to keep in motion and not feel "restrained" while receiving phototherapy. In addition it requires no eye protection furthering the infant's comfort level. Irradiation data, collected using a 460-520 nm wavelength light meter found that the prototype projected a physical irradiance of 48.2 Wnm-2cm-3. This is well above the irradiance level (30 Wnm-2cm-3)required to attain maximum breakdown of bilirubin. This study demonstrates that this type of device could be used to treat neonatal jaundice efficaciously while reducing infant stress as compared to traditional phototherapy methods.